Patents by Inventor Kangyi Zhang

Kangyi Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12133857
    Abstract: The present disclosure discloses a method for prolonging half-life of theanine in vivo. According to the present disclosure, a specific theanine glycoside compound formed by modification with a specific monosaccharide is used for prolonging the half-life of the theanine in vivo, which can be used for preparing sustained release drugs, prolonging action time of drugs, reducing administration frequency and improving compliance of patients. With the method of the present disclosure, the theanine glycoside compound obtained after modification can have a broad application prospect and a high commercial value in scientific research and clinical application.
    Type: Grant
    Filed: May 29, 2024
    Date of Patent: November 5, 2024
    Assignee: Anhui Agricultural University
    Inventors: Yijun Wang, Zhipeng Kan, Xiaochun Wan, Jinbao Huang, Kangyi Zhang, Yunqiu Yang, Xiaoyu Tang
  • Publication number: 20240316081
    Abstract: The present disclosure discloses a method for prolonging half-life of theanine in vivo. According to the present disclosure, a specific theanine glycoside compound formed by modification with a specific monosaccharide is used for prolonging the half-life of the theanine in vivo, which can be used for preparing sustained release drugs, prolonging action time of drugs, reducing administration frequency and improving compliance of patients. With the method of the present disclosure, the theanine glycoside compound obtained after modification can have a broad application prospect and a high commercial value in scientific research and clinical application.
    Type: Application
    Filed: May 29, 2024
    Publication date: September 26, 2024
    Inventors: Yijun WANG, Zhipeng Kan, Xiaochun Wan, Jinbao Huang, Kangyi Zhang, Yunqiu Yang, Xiaoyu Tang
  • Publication number: 20190125772
    Abstract: Disclosed are pharmaceutical compositions and methods of treating multiple myeloma by providing a pharmaceutically effective amount of each drug in a combination of drugs.
    Type: Application
    Filed: May 4, 2016
    Publication date: May 2, 2019
    Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, NATIONAL UNIVERSITY OF SINGAPORE
    Inventors: Dean HO, Chih-Ming HO, Aleidy Marlene Silva VITE, Kangyi ZHANG, Edward Kai-Hua CHOW, Tan Boon TOH, Wee Joo CHNG, Masturah Mohd Abdul RASHID
  • Patent number: 8658401
    Abstract: Disclosed is a method for preparing L-?-Glycerylphosphorylcholine with high yields and purity. The method uses phospholipase A1-based enzymatic hydrolysis, ion-exchange resin purification and silica gel column chromatography to prepare L-?-glycerylphosphorylcholin with purity up to 99.8% and a final yield up to 78.4%. The method disclosed is simple, cost-effective, environmentally friendly, and adaptable to industrial applications.
    Type: Grant
    Filed: March 24, 2011
    Date of Patent: February 25, 2014
    Assignee: Jiannan University
    Inventors: Yuanfa Liu, Kangyi Zhang, Xingguo Wang, Xiangyun Qian, Li Zhou, Zhihua Song
  • Publication number: 20120244583
    Abstract: Disclosed is a method for preparing L-?-Glycerylphosphorylcholine with high yields and purity. The method uses phospholipase A1-based enzymatic hydrolysis, ion-exchange resin purification and silica gel column chromatography to prepare L-?-glycerylphosphorylcholin with purity up to 99.8% and a final yield up to 78.4%. The method disclosed is simple, cost-effective, environmentally friendly, and adaptable to industrial applications.
    Type: Application
    Filed: March 24, 2011
    Publication date: September 27, 2012
    Inventors: Yuanfa Liu, Kangyi Zhang, Xingguo Wang, Xiangyun Qian, Li Zhou, Zhihua Song